3-substituted propanamine compounds
US8101642B2 · kind B2 · utility
1Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2009 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Dec 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I):or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also disclosed. The subject compounds are useful for the treatment of diseases of the central nervous system, such as depression, anxiety and pain disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.